1. Home
  2. BCAX vs OFIX Comparison

BCAX vs OFIX Comparison

Compare BCAX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • OFIX
  • Stock Information
  • Founded
  • BCAX 2018
  • OFIX 1987
  • Country
  • BCAX United States
  • OFIX United States
  • Employees
  • BCAX N/A
  • OFIX N/A
  • Industry
  • BCAX
  • OFIX Medical/Dental Instruments
  • Sector
  • BCAX
  • OFIX Health Care
  • Exchange
  • BCAX NYSE
  • OFIX Nasdaq
  • Market Cap
  • BCAX 670.9M
  • OFIX 648.7M
  • IPO Year
  • BCAX 2024
  • OFIX N/A
  • Fundamental
  • Price
  • BCAX $12.66
  • OFIX $16.01
  • Analyst Decision
  • BCAX Strong Buy
  • OFIX Strong Buy
  • Analyst Count
  • BCAX 6
  • OFIX 4
  • Target Price
  • BCAX $34.20
  • OFIX $23.33
  • AVG Volume (30 Days)
  • BCAX 611.7K
  • OFIX 209.6K
  • Earning Date
  • BCAX 03-27-2025
  • OFIX 05-06-2025
  • Dividend Yield
  • BCAX N/A
  • OFIX N/A
  • EPS Growth
  • BCAX N/A
  • OFIX N/A
  • EPS
  • BCAX N/A
  • OFIX N/A
  • Revenue
  • BCAX N/A
  • OFIX $799,491,000.00
  • Revenue This Year
  • BCAX N/A
  • OFIX $4.87
  • Revenue Next Year
  • BCAX N/A
  • OFIX $6.40
  • P/E Ratio
  • BCAX N/A
  • OFIX N/A
  • Revenue Growth
  • BCAX N/A
  • OFIX 7.08
  • 52 Week Low
  • BCAX $11.10
  • OFIX $12.08
  • 52 Week High
  • BCAX $28.09
  • OFIX $20.73
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • OFIX 36.74
  • Support Level
  • BCAX N/A
  • OFIX $15.50
  • Resistance Level
  • BCAX N/A
  • OFIX $16.45
  • Average True Range (ATR)
  • BCAX 0.00
  • OFIX 0.46
  • MACD
  • BCAX 0.00
  • OFIX -0.02
  • Stochastic Oscillator
  • BCAX 0.00
  • OFIX 34.00

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Share on Social Networks: